5595.T stock jumps 6.96% after hours on 15 Jan 2026: earnings due 20 Jan could set direction
5595.T stock after-hours move ahead of 20 Jan 2026 earnings; Meyka AI projects JPY 2,245.13 yearly forecast
-
-
S&S Intervalue China (8506.HK) jumps 37.89% intraday to HK$1.31: high volume move merits follow-up
Intraday high-volume move for 8506.HK stock to HK$1.31 on 15 Jan 2026; volume 4,140,000. Meyka AI analysis and short-term forecast
-
€0.005 pre-market: 1O2.F Exro Technologies (XETRA) 15 Jan 2026: bounce setup
1O2.F stock trades at €0.005 pre-market on XETRA; oversold bounce risk-reward and a model forecast to €0.04, plus Meyka grade
-
January 15: Minnesota Appeals CMS Move to Withhold $2B Medicaid Funding
Minnesota Medicaid funding faces a $2B challenge as the state appeals CMS withholding tied to a fraud probe. What it means for budgets, providers, and investors.
-
VR.CN Victory Resources (CNQ) C$0.10 15 Jan 2026: high-volume mover, watch catalysts
VR.CN stock moved to C$0.10 on 15 Jan 2026 in heavy trading. Quick analysis, grade, and a C$0.20 12-month forecast for VR.CN stock
-
VTG.AX stock up 79.57% on heavy volume: A$0.145 trade signals interest
VTG.AX stock jumps 79.57% to A$0.145 on heavy volume at ASX close 15 Jan 2026
-
January 15: P&H HC Says Criminal Cases vs Doctors Need Expert Opinion
Punjab and Haryana High Court rules criminal prosecutions for medical negligence need independent expert opinion, easing litigation risk for hospitals and insurers in India.
-
SYNI Synvista Therapeutics (PNK) 15 Jan 2026 Market Hours: Oversold bounce setup
SYNI stock plunged to $0.000 in market hours; we review oversold bounce setup, catalysts, risks, and Meyka AI forecast
-
INTRADAY GEPIL.BO GE Power India INR 360.10 15 Jan 2026: Oversold bounce signal
Intraday oversold bounce on GEPIL.BO stock at INR 360.10 with Meyka grade B and model forecast 329.84 INR
-
15,112 pre-market spike: ORPH.IR Open Orphan Plc EURONEXT 15 Jan 2026, watch 0.14
Pre-market volume spike for ORPH.IR stock to **15,112** shares at **EUR 0.14** on EURONEXT
